Clinical Studies

MERITAGE

This feasibility study, which enrolled 53 patients, was conducted in five clinical centers in three countries – United States, England, and Israel. It is evaluating epimacular beta radiation therapy when used to treat wet AMD drug persistence in those subjects who previously received anti-VEGF therapy. The company intends to present 24 month data from this study in Q4, 2011.